Document is current

Article History

Received: 5 March 2025

Accepted: 12 May 2025

First Online: 12 June 2025

Declarations

:

: Jeffrey L. Bennett has served as a Consultant for Horizon Therapeutics, Genentech, TG Therapeutics, Reistone Bio, Roche, Antigenomycs, Chugai, Mitsubishi Tanabe, EMD Serono, Beigene, Novartis, and ImCyse. He has served on scientific advisory and Data Safety Monitoring boards for Clene Nanomedicine and Roche. He serves on a Speakers Bureau for Alexion and received research support from Novartis and Alexion. Asha Paireddy is an employee of UCB. Charlotte Cox is an employee of Adelphi Values, a health outcomes agency that was commissioned by UCB to conduct the research. Megan Mayhew is an employee of Adelphi Values, a health outcomes agency that was commissioned by UCB to conduct the research. Julia Stein is an employee of Adelphi Values, a health outcomes agency that was commissioned by UCB to conduct the research. Teresa Gasalla is an employee of UCB. Béatrice Tugaut is an employee and shareholder of UCB.

: This study was conducted in accordance with the Declaration of Helsinki, International Conference on Harmonization guidelines for Good Clinical Practice, and other current data-protection guidance. Ethical approval was provided by Western Copernicus Group Independent Review Board (IRB #20222224; valid from December 19, 2022 to May 2, 2023). Written informed consent was obtained from each patient and clinician prior to study participation.